Product information
From Health Canada
Current status:
Marketed
Current status date:
2018-03-28
Original market date: See footnote 1
1991-12-31
Product name:
ANTICOAGULANT CITRATE DEXTROSE SOLUTION USP (ACD) FORMULA A
Description:
FOR USE WITH CYTAPHERESIS DEVICE ONLY
DIN:
00788139 Electronic product monograph is not available
Company:
FRESENIUS KABI AG
Else-Kroner-Strasse 1
Bad Homburg
Hessen
Germany
61346
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
0-Unassigned
Number of active ingredient(s):
3
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
20:12.04.92
Anatomical Therapeutic Chemical (ATC): See footnote 4
V07AC BLOOD TRANSFUSION, AUXILIARY PRODUCTS
Active ingredient group (AIG) number:See footnote5
0300464001
Active ingredient(s) | Strength |
---|---|
CITRIC ACID | 730 MG / 100 ML |
DEXTROSE | 2.45 G / 100 ML |
SODIUM CITRATE | 2.2 G / 100 ML |